Skip to content
Disclosery

EXANE DERIVATIVES: FANG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on FANG, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 9,666 FANG shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 9,666 shares
    Change vs previous 13F +645 shares

    0.67% of the 13F portfolio, value $1,170,797.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 9,021 shares
    Change vs previous 13F -355 shares

    0.35% of the 13F portfolio, value $1,236,522.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 9,376 shares
    Change vs previous 13F +9,346 shares

    0.25% of the 13F portfolio, value $1,011,165.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 30 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $2,840.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 30 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $2,701.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 30 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $2,205.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 30 shares
    Change vs previous 13F -28,880 shares

    <0.01% of the 13F portfolio, value $1,452.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 28,910 shares
    Change vs previous 13F not available

    0.28% of the 13F portfolio, value $870,721.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).